Activity of Brigatinib in Crizotinib and Ceritinib-Resistant ROS1- Rearranged Non–Small-Cell Lung Cancer

Lignende værker

• Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report
  af: Subbiah, Vivek, et al.
  Udgivet: (2016)
• Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
  af: Shaw, Alice T., et al.
  Udgivet: (2014)
• The role of brigatinib in crizotinib-resistant non-small cell lung cancer
  af: Mezquita, Laura, et al.
  Udgivet: (2018)
• ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
  af: Suryavanshi, Moushumi, et al.
  Udgivet: (2017)
• Crizotinib in ROS1 rearranged non-small cell lung cancer (NSCLC), from response to resistance
  af: Zhong, Eric, et al.
  Udgivet: (2016)